PharVision Advisers’s LKQ Corp LKQ Stock Holding History

PharVision Advisers’s Portfolio LKQ Stock Details LKQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9,690	Closed	-$356K	–	408
2024 Q4	$356K	Buy	+9,690	New	+$370K	0.3%	105

Other funds holding LKQ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

PharVision Advisers's LKQ Position: Q1 2025 in Review

PharVision Advisers sold out of LKQ Corp (LKQ) in Q1 2025, closing a stake of 9,690 shares — an estimated $356K sold.

PharVision Advisers first reported a position in LKQ in Q4 2024 and held it in 1 quarter. The position peaked at $356K in Q4 2024. 654 funds tracked by Wall St. Rank hold LKQ as of Q1 2025.

PharVision Advisers reported no remaining LKQ Corp position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 9,690 LKQ Corp shares in Q1 2025, an estimated $356K.
PharVision Advisers first reported a position in LKQ Corp in Q4 2024 and held it in 1 quarter.
PharVision Advisers's LKQ Corp position peaked at $356K in Q4 2024.
654 funds tracked by Wall St. Rank held LKQ Corp as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.